Market Tracker

04/24 6:02pm ET

ImmunoGen Inc (NASDAQ:IMGN)

9.96
Delayed Data
As of Apr 24
 -0.29 / -2.83%
Today’s Change
5.34
Today|||52-Week Range
14.17
+63.28%
Year-to-Date

Today’s Trading

Previous close10.25
Today’s open9.50
Day’s range9.02 - 10.20
Volume2,821,356
Average volume (3 months)1,646,891
Market cap$857.6M
Dividend yield--
Data as of 4:00pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+20.44%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales8.71
Price/Book11.30

Competitors

 Today’s
change
Today’s
% change
CHRSCoherus Biosciences ...-0.88-3.61%
OVASOvaScience Inc-0.55-1.78%
RTRXRetrophin Inc+0.01+0.04%
ANIPANI Pharmaceuticals ...-1.52-2.12%
Data as of 4:00pm ET, 04/24/2015

Financials

Last reporting dateApril 24, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts